Atlas Trials

A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)

Clinical trial NCT05201144 · RECRUITING

Trial details

NCT number
NCT05201144
Sponsor
University of Utah
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Congenital Diaphragmatic HerniaPulmonary Hypertension
Start date
2022-09-15
Primary completion
2026-03-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.